000 01281 a2200373 4500
005 20250513183856.0
264 0 _c19990622
008 199906s 0 0 eng d
022 _a0002-9149
024 7 _a10.1016/s0002-9149(99)00210-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRader, D J
245 0 0 _aPathophysiology and management of low high-density lipoprotein cholesterol.
_h[electronic resource]
260 _bThe American journal of cardiology
_cMay 1999
300 _a22F-24F p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aBezafibrate
_xtherapeutic use
650 0 4 _aCholesterol, HDL
_xblood
650 0 4 _aCoronary Disease
_xetiology
650 0 4 _aDiet
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHyperlipidemias
_xtherapy
650 0 4 _aHypertriglyceridemia
_xcomplications
650 0 4 _aHypolipidemic Agents
_xtherapeutic use
650 0 4 _aLife Style
650 0 4 _aLipoproteins, HDL
_xphysiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRisk Factors
773 0 _tThe American journal of cardiology
_gvol. 83
_gno. 9B
_gp. 22F-24F
856 4 0 _uhttps://doi.org/10.1016/s0002-9149(99)00210-6
_zAvailable from publisher's website
999 _c10316191
_d10316191